| #83 |
Juliette Segolène GUAQUIÈRE |
Viiv Healthcare |
1 |
| #83 |
Coulton Legge |
— |
1 |
| #83 |
Tristan Fairbrother |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #83 |
Rodger Phillip Barnett |
Glaxo Group Limited |
1 |
| #83 |
Colin B. Sidgwick |
Glaxo Group Limited |
1 |
| #83 |
Ismail Vali-Tepper |
— |
1 |
| #83 |
Andrew Roderick Taylor |
Glaxo Group Limited |
1 |
| #83 |
Susan V. Wolfe |
International Standard Electric |
1 |
| #83 |
Ann Chappell |
— |
1 |
| #83 |
Bergeal David |
Johnson Matthey Public Limited |
1 |
| #83 |
Joseph Paul Marino |
Glaxo Group Limited |
1 |
| #83 |
Laurie Kwok |
Glaxo Group Limited |
1 |
| #83 |
Mike Golding |
Xerox |
1 |
| #83 |
Robert Hermann Gibbon |
Glaxosmithkline |
1 |
| #83 |
Ernest N. Clegg |
Uop |
1 |
| #83 |
Colin D. Eldred |
Sanofi |
1 |
| #83 |
Keith D. Bringloe |
— |
1 |
| #83 |
Ernest Kemp |
— |
1 |
| #83 |
Frederick Albinson |
Glaxo Group Limited |
1 |
| #83 |
Trevor Leslie Ilott |
— |
1 |
| #83 |
Patricia Burnell |
Glaxo Group Limited |
1 |
| #83 |
Marsha R. Ratcliff |
— |
1 |
| #83 |
Claire J. Lovegrove |
Merck |
1 |
| #83 |
Roger Stables |
Glaxo Group Limited |
1 |
| #83 |
David Rickman |
Smith & Nephew, Inc., Research |
1 |
| #83 |
David A. Saynor |
Glaxo Group Limited |
1 |
| #83 |
Steven F. Beach |
Glaxo Group Limited |
1 |